Aurora Therapeutics
13 employees on LinkedIn · 1 known investors
Aurora develops a platform for personalized gene editing to treat rare genetic diseases at scale. The company targets patients with rare disease variants by systematizing and scaling gene editing treatments to address genetic mutations that lack existing therapeutic options.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeedFeb 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 3
by search overlap
Aura Biosciences11 shared keywordsAura Biosciences develops Virus-Like Drug Conjugates (VDCs), a platform using Virus-Like Particles conjugated with drugs or loaded with nucleic acids to target solid tumors. Its lead focus is treating choroidal melanoma, a rare ocular cancer for which no first-line drug therapies currently exist.
Aro Biotherapeutics10 shared keywordsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Aurora Pharmaceutical9 shared keywordsAurora Pharmaceutical is a pharmaceutical company whose site references veterinary care, indicating a focus on animal health products and treatments. The page provides only legal terms of use, so details on specific products are limited.
Companies competing with Aurora Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Aurora Therapeutics do?
- Aurora develops a platform for personalized gene editing to treat rare genetic diseases at scale. The company targets patients with rare disease variants by systematizing and scaling gene editing treatments to address genetic mutations that lack existing therapeutic options.
- Who are Aurora Therapeutics's investors?
- Aurora Therapeutics's investors include Menlo Ventures.